Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

Diabetes

Volumn 43, Issue 4, 1994, Pages 535-539

  Ørskov, Cathrine ^a   Rabenhøj, Lise ^a   Wettergren, André ^b   Kofod, Hans ^c   Holst, Jens J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

AMIDATION; ARTICLE; CARDIOVASCULAR SYSTEM; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; FOOD INTAKE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PANCREAS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMALL INTESTINE;

EID: 0028281773     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.43.4.535     Document Type: Article

References (22)

1. Bell GI, Sanchez-Pescador R, Layboum PJ, Najarian RC,- Exon duplication and divergence in the human preproglucagon gene. Nature 304:368-71, 1983
2. Ørskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-81, 1987
3. Ørskov C, Bersani M, Johnsen AJ, Højrup P, Holst JJ: Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 264:12826-29, 1989
4. Kreymann B, Ghatei MA, Williams G, Bloom SR: Glucagon-like peptide 1 7-36: a physiological incretin in man. Lancet 2:1300-303, 1987
5. Eipper BA, Mains RE, Glembotski CC: Identification in pituitary tissue of a peptide α-amidation activity that acts on glycine-extended peptides and requires molecular oxygen, copper, and ascorbic acid. Proc Natl Acad Sci USA 80:5144-48, 1983
6. Hilsted L: Review: glycine-extended gastrin precursors. Regul Pept 36:323-43, 1991
7. Mojsov S, Kopzcynski MG, Habener JF: Both amidated and nonamidated forms of glucagon-like-peptide I are synthesized in the rat intestine and the pancreas. J Biol Chem 265:8001-8008, 1990
8. McAloon Dyke M, Fukagawa NK, Habener JF, Andersen DK, Elahi D: The insulinotropic effect of GIP and GLP-I in healthy and diabetic subjects (Abstract). Regul Pept 40:205, 1992
9. Nathan DM, Schreiber E, Fogel H, Mojsov S, Habener JF: Insulinotropic action of glucagon-like peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 15:270-76, 1992
10. Ørskov C, Wettergren A, Holst JJ: Biological effects and metabolic rates of glucagon-like peptide I 7-36 amide and glucagon-like peptide I 7-37 in healthy subjects are indistinguishable. Diabetes 42:658-61, 1993
11. Gutniak M, Ørskov C, Holst JJ, Ahren B, Efendic S: Anti-diabetogenic effect of glucagon-like peptide I (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-22, 1992
12. Nauck MA, Heimesaat M, Ørskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin effect of glucagon-like peptide I (7-36) amide but not of synthetic human gastric inhibitory polypeptide (GIP) in patients with type II diabetes. J Clin Invest 91:301-307, 1993
13. Wettergren A, Scholdager B, Mortensen PE, Myhre J, Christiansen J, Hoist JJ: Truncated GLP-I (proglucagon 78-107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665-73, 1993
14. Scholdager BTG, Mortensen PE, Christiansen J, Ørskov C, Holst JJ: GLP-I (glucagon-like peptide I) and truncated GLP-I fragments of human proglucagon inhibit gastric acid secretion in man. Dig Dis Sci 35:703-708, 1989
15. O'Halloran DJ, Nikou GC, Kreymann B, Ghatei M, Bloom SR: Glucagon-like peptide I (7-36) NH2: a physiological inhibitor of gastric acid secretion in man. J Endocrinol 126:169-73, 1990
16. Newgard CB, Holst JJ: Heterogeneity of somatostatin-like immunoreactivity in extracts of porcine, canine, and human pancreas. Acta Endocrinol 98:564-72, 1981
17. Ørskov C, Jeppesen J, Madsbad S, Holst JJ: Proglucagon products in plasma in non-insulin-dependent diabetics and nondiabetic controls in the fasting state and following oral glucose and intravenous arginine. J Clin invest 87:415-23, 1990
18. Barany G, Merrifleld RB: The Peptides. Vol. 2. Gross E, Meienhofer J, Eds. New York, Academic Press, 1979, p. 3-284
19. N2 deprotection of synthetic peptides with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J Am Chem Soc 105:6442-46, 1983
20. 10]porcine secretin. Int J Pept Protein Res 37:185-90, 1991
21. Elliott R, Morgan L, Tredger J, Charles S, Wright J, Marks V: glucagon-like peptide I (7-36) amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24-hour secretion patterns. J Endocrinol 138:159-66, 1993
22. Orskov C, Andreasen J, Holst JJ: All products of proglucagon are elevated in plasma from uremic patients. J Clin Endocrinol Metab 74:379-84, 1992